Ortho Clinical Diagnostics, Raritan, New Jersey, has been awarded a not-to-exceed $45,550,000 firm-fixed-price, undefinitized contract action to support the COVID-19 response and will increase production capacity of the U.S. COVID-19 antibody and antigen test kit assays as well as test analyzers. This contract will allow Ortho Clinical Diagnostics to order long-lead equipment to establish a domestic production capability of VITROS® Systems and SARS-CoV-2 Antigen and Antibody Tests at its Rochester, New York, Global Center of Excellence facility for Research and Development. Work is expected to be completed March 2022. This award is the result of a sole-source acquisition. Fiscal 2021 other procurement funds in the amount of $10,856,112 are being obligated at the time award. Air Force Life Cycle Management Center, Hanscom Air Force Base, Massachusetts, is the contracting activity (FA8726-21-C-0005).
Recommended
free preview